Natrixam (Indapamide, Amlodipine Besilate)

Indapamide acts as a thiazide‑like diuretic, blocking sodium reabsorption in the kidney’s distal tubule, which increases urine output and lowers fluid volume. Amlodipine blocks L‑type calcium channels in vascular smooth muscle, causing vasodilation. Together they lower peripheral resistance and blood volume, decreasing blood pressure.

The specific dose of Natrixam is determined by the prescribing clinician based on the individual’s blood pressure, medical history, and response to therapy. Patients should follow the exact dosage instructions provided by their healthcare professional.

Safety of Natrixam in pregnancy or while nursing has not been definitively established. Healthcare providers should weigh potential benefits against possible risks and discuss alternative treatment options with patients who are pregnant, planning pregnancy, or breastfeeding.

To request Natrixam, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Natrixam combines a thiazide‑like diuretic with a calcium‑channel blocker, offering dual mechanisms that can be more effective than monotherapy for some patients. Compared with single‑agent ACE inhibitors or beta‑blockers, the combination may provide better blood pressure control with a single pill, though individual response varies.

Natrixam tablets should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original container, protect it from moisture and direct sunlight, and ensure the packaging remains tightly closed until use.

Natrixam is taken orally, usually once daily, with or without food as directed by a healthcare professional. Swallow the tablet whole with a full glass of water; do not crush, chew, or split the tablet unless specifically instructed.

The most serious risks include severe hypotension, which can cause fainting or shock, and electrolyte disturbances such as low potassium or sodium levels that may lead to cardiac arrhythmias. Liver function abnormalities and rare cases of hepatic injury have also been reported.

Patients with known hypersensitivity to indapamide, amlodipine, or any component of the formulation should avoid Natrixam. It is also contraindicated in individuals with severe renal impairment, uncontrolled heart failure, or those taking medications that may cause dangerous interactions without proper monitoring.